dr reddy's glp-1 drugs portfolio 2025 Reddy’s Steps Up Biosimilars And Investments As Semaglutide Launch Nears India GLP-1 Receptor Agonist Market
Description
Liu L, Chen J, Wang L, Chen C, Chen L
recently studied the risk of broncho-aspiration in 886 patients who underwent esophagogastroduodenoscopies (EGDS) under general anesthesia
& Latz, E
Yes, oral semaglutide (Rybelsus) is available, improving accessibility for patients who prefer not to use injections
Fig.3 Proportion of patients achieving MASH resolution without worsening of fibrosis with tirzepatide [6] While GLP-1 RAs are proving effective in treating MASH, their lack of direct action on liver tissue could limit their effectiveness in patients with advanced liver fibrosis or cirrhosis
